Asarina Pharmas R&D-dag 2020 nu digital
Asarina Pharmas R&D dag torsdagen den 26 mars kommer att vara helt digital på grund av det nya coronaviruset. Fokus kommer att ligga på kommande… Read More »Asarina Pharmas R&D-dag 2020 nu digital
Other Corporate Information
Inbjudan till Asarina Pharmas R&D-dag 2020
Asarina Pharma bjuder in institutionella investerare, finansanalytiker och media till en R&D-dag med fokus på kommande studieresultat i bolagets ledande indikation PMDS. Datum: 26 mars… Read More »Inbjudan till Asarina Pharmas R&D-dag 2020
Invitation to Asarina Pharma R&D Day 2020
Asarina Pharma invites institutional investors, financial analysts and media to join its R&D day, focused on the upcoming Study results in the company's lead indication… Read More »Invitation to Asarina Pharma R&D Day 2020
Asarina Pharma issues new shares to Ergomed plc
(Stockholm, 20 February, 2020) Asarina Pharma AB (publ) (“Asarina Pharma” or the “Company”) today announces that it will, pursuant to the authorisation granted by the… Read More »Asarina Pharma issues new shares to Ergomed plc
Asarina Pharma emitterar 301 724 aktier till Ergomed plc
(Stockholm, 20 februari, 2020) Styrelsen i Asarina Pharma AB (publ) (“Asarina Pharma” eller ”Bolaget”) har, med stöd av bemyndigande från Bolagets extra bolagsstämma den 21… Read More »Asarina Pharma emitterar 301 724 aktier till Ergomed plc
Asarina Pharmas extra bolagsstämma
Asarina Pharma AB (publ) höll idag, den 21 januari 2020, extra bolagsstämma i Stockholm. Bolagsstämman valde styrelsens ordförande Paul de Potocki till stämmoordförande och advokat… Read More »Asarina Pharmas extra bolagsstämma
Asarina Pharma’s extraordinary general meeting
Today, on 21 January 2020, Asarina Pharma AB (publ) held an extraordinary general meeting (“EGM”) in Stockholm, Sweden. The EGM elected the chairman of the… Read More »Asarina Pharma’s extraordinary general meeting
NOTICE OF EXTRAORDINARY GENERAL MEETING IN ASARINA PHARMA AB (PUBL)
The shareholders of Asarina Pharma AB (publ) are hereby summoned to attend the Extraordinary General Meeting (“EGM”) on 21 January 2020, at 10.00 at Erik… Read More »NOTICE OF EXTRAORDINARY GENERAL MEETING IN ASARINA PHARMA AB (PUBL)
KALLELSE TILL EXTRA BOLAGSSTÄMMA I ASARINA PHARMA AB (PUBL)
Aktieägarna i Asarina Pharma AB (publ) kallas härmed till extra bolagsstämma den 21 januari 2020 kl. 10.00 i Erik Penser Banks lokaler, Apelbergsgatan 27 i… Read More »KALLELSE TILL EXTRA BOLAGSSTÄMMA I ASARINA PHARMA AB (PUBL)
First patient dosed in landmark Menstrual Migraine study
Asarina Pharma AB (publ) (ASAP: FN Stockholm) has administered the first dose in its Phase IIa trial of a new, preventative treatment for menstrual migraine.… Read More »First patient dosed in landmark Menstrual Migraine study